Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Boston Scientific government affairs: Scott Reid joins Boston Scientific's government affairs office as federal affairs director-health policy & payment. He replaces Sarah Wells, who left to become the global government affairs director at Amgen after seven years at Boston Scientific. Reid has worked on reimbursement issues for the past four years at Boston Scientific, including presenting before CMS' APC Advisory Panel to seek higher payment for the firm's Hydro ThermAblator endometrial ablation device (1"The Gray Sheet" Feb. 28, 2005, p. 6). He previously was the government relations manager at the American Urological Association from 1996-2001. Boston Scientific is looking for one other person to round out its D.C. office, which includes Legislative Affairs Director Steve LaPierre and International Health Policy Director Paul Barry...

You may also be interested in...



Terumo To End Guidewire And Sheath Distribution Deal With Boston Scientific

Terumo is creating its own U.S. sales force to sell guidewires and sheaths when its existing distribution arrangement with Boston Scientific expires in March 2006

Boston Scientific Fights For Higher HTA Payment, But Is Undercut By AMS

American Medical Systems' argument that its HerOption cryosurgical device requires ultrasonic guidance and therefore justifies higher payment than Boston Scientific's Hydro ThermAblator proved persuasive to CMS' APC Advisory Panel

UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026

Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023140

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel